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ttp://dx.doi.org/10.1016/j.ajpath.2014.10.010Epithelial barrier function is maintained by tight junction proteins that control paracellular ﬂuid ﬂux.
Among these proteins is junctional adhesion molecule A (JAM-A), an Ig fold transmembrane protein. To
assess JAM-A function in the lung, we depleted JAM-A in primary alveolar epithelial cells using shRNA. In
cultured cells, loss of JAM-A caused an approximately 30% decrease in transepithelial resistance,
decreased expression of the tight junction scaffold protein zonula occludens 1, and disrupted junctional
localization of the structural transmembrane protein claudin-18. Consistent with ﬁndings in other organs,
loss of JAM-A decreased b1 integrin expression and impaired ﬁlamentous actin formation. Using a model
of mild systemic endoxotemia induced by i.p. injection of lipopolysaccharide, we report that JAM-A/
mice showed increased susceptibility to pulmonary edema. On injury, the enhanced susceptibility of
JAM-A/mice to edema correlated with increased, transient disruption of claudin-18, zonula occludens 1,
and zonula occludens 2 localization to lung tight junctions in situ along with a delay in up-
regulation of claudin-4. In contrast, wild-type mice showed no change in lung tight junction
morphologic features in response to mild systemic endotoxemia. These ﬁndings support a key role
of JAM-A in promoting tight junction homeostasis and lung barrier function by coordinating in-
teractions among claudins, the tight junction scaffold, and the cytoskeleton. (Am J Pathol 2015,
185: 372e386; http://dx.doi.org/10.1016/j.ajpath.2014.10.010)Supported by Emory Alcohol and Lung Biology Center/NIH grant P50-
AA013757 (M.K.); NIH grants R01-HL083120 and R01-HL116958 (to
M.K.); AA-013528 (L.A.M.); R01-DK061379, R01-DK072564, and R01-
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Disclosures: None declared.To support efﬁcient gas exchange, the lung must maintain a
barrier between the atmosphere and ﬂuid-ﬁlled tissues.Without
this crucial barrier, the air spaces would ﬂood, and gas ex-
change would be severely limited.1,2 In acute lung injury and
acute respiratory distress syndrome, ﬂuid leakage into the lung
air space is associated with increased patient mortality and
morbidity.3,4 Lung ﬂuid clearance is maintained, in part, by
tight junctions that regulate paracellular ﬂux between cells.5e7
Tight junctions are multiprotein complexes located at sites
of cell-cell contact and are composed of transmembrane,
cytosolic, and cytoskeletal proteins that together produce
a selective barrier to water, ions, and soluble molecules.
Among the transmembrane proteins required for epithelial
barrier function is the Ig superfamily protein junctional
adhesion molecule A (JAM-A).8e11 JAM-A is ubiquitouslystigative Pathology.
.expressed and regulates several processes related to cell-cell
and cell-matrix interactions, including cell migration and
proliferation in addition to barrier function regulation. Spe-
ciﬁc mechanistic roles for JAM-A in regulating tight junc-
tions continue to be elucidated.
JAM-A Promotes Tight Junction AssemblyJAM-A signaling is stimulated by cis-dimerization, which
provides a platform for multiple proteins to cluster in close
apposition.12 In particular, JAM-A has been shown to re-
cruit scaffold proteins, such as zonula occludens 1 (ZO-1),
ZO-2, and Par3, to tight junctions, where these proteins
enhance the assembly of multiprotein junctional com-
plexes.13,14 More recently, it was demonstrated that JAM-A
directly interacts with ZO-2, which then recruits other
scaffold proteins, including ZO-1.15 This nucleates a core
complex that includes afadin, PDZ-GEF1, and Rap2c and
that stabilizes ﬁlamentous actin by repressing rhoA.15
Together, all of these activities of JAM-A promote tight
junction formation and barrier function.
Although JAM-A is part of the tight junction complex, the
main structural determinants of the paracellular barrier are
proteins known as claudins. Claudins are a family of trans-
membrane proteins that interact to form paracellular channels
that either promote or limit paracellular ion and water
ﬂux.16e18 Claudins that promote ﬂux are known collectively
as pore-forming claudins, whereas claudins that limit ﬂux are
known as sealing claudins.19 In fact, there is a link between
JAM-A and claudin expression because it was demonstrated
that JAM-Aedeﬁcient intestinal epithelium has increased
expression of two pore-forming claudins, claudin-10 and
claudin-15.20 Critically, increased claudin-10 and claudin-15
leads to a compromised intestinal barrier, as demonstrated by
an enhanced susceptibility of JAM-A/ mice to dextran
sulfate sodiumeinduced colitis.20 However, it is not known
whether this relationship between JAM-A and claudin
expression occurs in other classes of epithelia.
Several claudins are expressed by the alveolar epithelium.
Themost prominent alveolar claudins are claudin-3, claudin-4,
and claudin-18; several additional claudins are expressed
by alveolar epithelium and throughout the lung as
well.21,22 A central role for claudin-18 in regulating lung
barrier function was demonstrated in two independently
derived strains of claudin-18edeﬁcient mice that showed
altered alveolar tight junction morphologic features and
increased paracellular permeability.23,24 Claudin-4 also is
an important part of the lung response to acute lung injury
because it improves barrier function by limiting alveolar
epithelial permeability and promoting lung ﬂuid clear-
ance.25,26 Although claudin-4edeﬁcient mice show a
relatively mild baseline phenotype, these mice have
impaired ﬂuid clearance in response to ventilator-induced
lung injury.27 An analysis of ex vivo perfused human
donor lungs revealed that increased claudin-4 was linked
to increased rates of alveolar ﬂuid clearance and decreased
physiologic respiratory impairment,28 further underscoring
the importance of claudin regulation in promoting efﬁcient
barrier function in response to injury.
Although JAM-A has a clear role in regulating gut perme-
ability,20 a recent report that wild-type and JAM-A/ mice
show comparable levels of pulmonary edema in response to
intratracheal endotoxin challenge29 raises questions about
potential roles for JAM-A in lung barrier function. Herein weThe American Journal of Pathology - ajp.amjpathol.orgused a combination of in vivo and in vitro approaches to assess
the contributions of JAM-A to alveolar barrier function. Using
a model of mild systemic endotoxemia induced by i.p. injec-
tion of Escherichia coliederived lipopolysaccharide (LPS),
we found that JAM-A/ mice showed greater lung edema
than comparably treated wild-type mice. Greater sensitivity to
injury was due to aberrant regulation of tight junction protein
expression, which was recapitulated by JAM-Ae
depleted alveolar epithelial cells. JAM-A depletion also
resulted in decreased b1 integrin protein levels and dis-
rupted cytoskeletal assembly. Together, these effects indi-
cated that the loss of JAM-A impaired tight junction
formation, thus rendering the lung more susceptible to
edema and injury.
Materials and Methods
Materials
Unless otherwise speciﬁed, materials were fromSigma-Aldrich
(St. Louis, MO). AntieJAM-A, claudin-3, claudin-4,
claudin-5, claudin-7, claudin-10, claudin-15, claudin-18,
occludin, ZO-1, ZO-1 actin, and b1 integrin were from Life
Technologies (Grand Island, NY). E-cadherin antibodies were
from Cell Signaling Technology Inc. (Danvers, MA). Mini-
mally cross-reactive ﬂuorescent and horseradish peroxidase
secondary antibodies were from Jackson ImmunoResearch
Laboratories (West Grove, PA).
Isolation and Culture of Rat Type II Alveolar Epithelial
Cells
The animal protocols were reviewed and authorized by the
Institutional Animal Care and Use Committee of Emory
University (Atlanta, GA). Sprague-Dawley rat type II alve-
olar epithelial cells were isolated from lungs lavaged and
perfused with elastase as described elsewhere,30 with modi-
ﬁcations.31 Preparations routinely contained >90% to 95%
type II alveolar epithelial cells. Freshly isolated cells were
cultured in Eagle’s minimal essential medium (Life Tech-
nologies, Rockville, MD) containing 10% fetal bovine serum,
25 mg/mL gentamicin, and 0.25 mg/mL amphotericin B (Life
Technologies) in Transwells coated with rat tail type I
collagen (Roche Diagnostics GmbH, Mannheim, Germany)
at 7.5  105 cells/mL, as described elsewhere.32 Trans-
epithelial resistance of cells in medium cultured on permeable
supports was measured using an ohmmeter (World Precision
Instruments, Sarasota, FL), as previously described.33,34
Lentiviral shRNA shuttle vector pFH1þU6-UG-W was
modiﬁed from pFH1UGW35 using standard molecular tech-
niques to include the H1 and U6 promoters to drive shRNA
production (Table 1). Lentiviral particles were produced by
the Emory Neuroscience National Institute of Neurological
Disorders and Stroke Viral Vector Core Facility. For shRNA
knockdown, freshly isolated rat alveolar epithelial cells were
cultured, with lentiviral vector constructs added to the apical373
Table 1 shRNA Constructs Used in This Study
JAM-A shRNA1 616e624
Sense 50-(NheI)CCCCGCCTTCATCAATTCTTCATTTCAAGAGAATGAAGAATTGATGAAGGC TTTTTGG(PacI)-30
Antisense 50-(PacI)CCAAAAAGCCTTCATCAATTCTTCATTCTCTTGAAATGAAGAATTGATGAAGGC GGGG(NheI)-30
JAM-A shRNA2 1594e1612
Sense 50-(NheI)CCCCGTGGCTGTTAGTCACTTCATTCAAGAGATGAAGTGACTAACAGCCACTTTTTGG(PacI) -30
Antisense 50-(PacI)CCAAAAAGTGGCTGTTAGTCACTTCATCTCTTGAATGAAGTGACTAACAGCCACGGGG(NheI)-30
Scrambled
Sense 50-(NheI)CCCCAGTCATTGACGACAGCGTATTCAAGAGATACGCTGTCGTCAATGACTTTTTTGG(PacI)-30
Antisense 50-(PacI)CCAAAAAAGTCATTGACGACAGCGTATCTCTTGAATACGCTGTCGTCAATGACTGGGG(NheI)-30
Mitchell et aland basal sides, and were incubated for 24 hours, followed by
a medium change. Lentiviral titers were adjusted to maximize
JAM-A repression and cell viability.
Biochemical Analysis
After 6 days in culture, cells on permeable supports were
harvested and lyzed in 2 sample buffer containing 50
mmol/L dithiothreitol, resolved by SDS-PAGE, transferred
to Immobilon membranes (Millipore, Billerica, MA), and
blotted using primary antibodies and horseradish perox-
idaseeconjugated goat anti-rabbit IgG or goat anti-mouse
IgG. Speciﬁc signals corresponding to a given protein were
detected by immunoblot analysis using enhanced chem-
iluminescence reagent (GE Healthcare, Pittsburgh, PA) and
were quantiﬁed using Image Lab software version 2.0.1,
build 18 (Bio-Rad Laboratories, Hercules, CA). Normali-
zation for protein content was performed using parallel
samples analyzed for actin. Statistical signiﬁcance was
determined by Student’s t-test or analysis of variance as
appropriate.
Immunoﬂuorescence Staining
Immunoﬂuorescence staining was performed as described
elsewhere.33,34 After 6 days in culture, the cells were
washed with phosphate-buffered saline (PBS) three times,
ﬁxed in methanol/acetone 1:1 for 2 minutes at room
temperature, and washed three times with PBS, once with
PBS þ 0.5% Triton X-100 (Roche Diagnostics GmbH),
and then once with PBS þ 0.5% Triton X-100 þ 2%
normal goat serum. Cells were incubated with primary
anti-rabbit and/or anti-mouse antibodies in PBS þ 2%
normal goat serum for 1 hour, washed, incubated with
Cy2-conjugated goat anti-rabbit IgG and Cy3-conjugated
goat anti-mouse IgG (Jackson ImmunoResearch Labora-
tories) in PBS þ 2% normal goat serum, washed, and then
mounted in Mowiol medium (Kuraray America Inc.,
Houston, TX) under a glass coverslip. Cells were imaged
by phase-contrast and ﬂuorescence microscopy using an
Olympus IX70 microscope with a U-MWIBA ﬁlter pack
(BP460e490, DM505, BA515e550) or a U-MNG ﬁlter
pack (BP530e550, DM570, BA590e800þ) or by
confocal immunoﬂuorescence microscopy using an
Olympus Fluoview FV1000 system (Olympus America374Inc., Center Valley, PA). Minimum and maximum in-
tensity were adjusted for images in parallel so that the
intensity scale remained linear to maximize dynamic
range.
Mice
The mice used consisted of C57BL/6 (wild-type) mice (The
Jackson Laboratory, Bar Harbor, ME) or JAM-A/ mice36
backcrossed onto C57BL/6 for seven generations as
described elsewhere.20
LPS Administration
C57BL/6 or JAM-A/ mice at 6 to 8 weeks of age were
either untreated or i.p. injected with either control saline
(PBS) or PBS containing 1 mg/kg LPS from E. coli strain
O111:B6 (Sigma-Aldrich). Lungs were collected 0, 6, 24,
and 48 hours after treatment and were processed for total
lung protein analysis, histologic analysis, or determination
of the wet/dry ratio.
Total Lung Protein Analysis
Lungs from mice were removed and snap frozen using
liquid nitrogen. The samples were homogenized in 1 mL of
radioimmunoprecipitation assay buffer (20 mmol/L Tris,
pH 7.4, 2 mmol/L EDTA, 2 mmol/L EGTA, 150 mmol/L
NaCl, 1% Triton X-100, 1% sodium deoxycholate, and
0.1% SDS) containing 1 tablet per 10 mL complete protease
inhibitors.25 The samples were microfuged at 5000  g for 5
minutes, and the supernatant was analyzed by immunoblot
as described in Biochemical Analysis.
Histologic Analysis
Lung sections (6 mm) were ﬁxed with 4% paraformaldehyde
for 10 minutes, processed for frozen thin sections, and then
stained with hematoxylin and eosin or immunostained as
described elsewhere.33,37,38 For determination of pulmonary
edema, lungs were removed, placed on a preweighed piece
of aluminum foil, and weighed. Lungs were then heated to
65C for 24 hours and weighed again. The ratio of wet lung
mass/dry lung mass was calculated to give a measure of the
water content of the tissue.39ajp.amjpathol.org - The American Journal of Pathology
Figure 1 JAM-A/ mice have decreased lung
zonula occludens 1 (ZO-1) expression. A: Lungs
were harvested from littermate control mice (þ/þ)
or JAM-A/ mice (/) and homogenized in a
protease inhibitor cocktail, and proteins were
resolved by SDS-PAGE, analyzed by immunoblot,
and quantiﬁed as described in Materials and
Methods. Of the tight junction proteins examined,
claudin-5 (Cldn-5), Cldn-7, and ZO-1 levels were
signiﬁcantly different in lungs from JAM-A/mice
compared with those from wild-type mice. JAM-A is
undetectable in JAM-A/ mice. B: Representative
immunoblots. Data are expressed as means  SD.
nZ 4. *P < 0.05.
JAM-A Promotes Tight Junction AssemblyResults
JAM-A/ mice have previously been shown to have a
defect in intestinal permeability linked to changes in tight
junction protein expression.15,20 Therefore, we characterized
tight junction protein content of whole lungs of JAM-A/
mice (Figure 1). We examined two PDZ scaffold proteins,
ZO-1 and ZO-2, which are regulated by JAM-A.15 Only
ZO-1 showed a signiﬁcant decrease in lung expression
compared with that observed in wild-type mice
(Figure 1). There was a mean  SD 34%  15% decrease
(n Z 4) in total lung ZO-1 expression in JAM-A/ mice
compared with controls. In contrast, levels of total lung
ZO-2 were unchanged in JAM-A/ mice. Occludin
expression was also unchanged in lungs of JAM-A/
mice.
We then focused on claudin expression. Of the claudins
examined, only claudin-5 and claudin-7 showed small, but
statistically signiﬁcant, changes when comparing totalThe American Journal of Pathology - ajp.amjpathol.orglysates of lungs from JAM-A/ mice with those from
littermate controls. Claudin-5 levels increased by a mean 
SD of approximately 17% 10% (nZ 4), whereas claudin-7
levels decreased by 15% 3% (nZ 4). Claudin-4, claudin-10,
and claudin-18 levels trended downward in response to loss
of JAM-A, and the remaining claudins examined (claudin-1,
claudin-2, claudin-3, claudin-4, claudin-8, claudin-10,
claudin-15, claudin-18, and claudin-23) did not show sig-
niﬁcant differences between JAM-Aedeﬁcient lungs and
lungs from littermate controls. Levels of pore-forming
claudin-10 and claudin-15), which are up-regulated in the
intestine of JAM-A/mice and contribute to an increase in
gut permeability,20 were not increased in the lungs of JAM-
A/ mice. These results suggest that JAM-A deﬁciency
has different effects on claudin expression in the lungs than
in the gut.
Consistent with small changes to total tight junction pro-
tein expression at baseline, lungs of wild-type and JAM-A/
mice had comparable mean SD ﬂuid content as determined375
Figure 2 Depletion of JAM-A protein impairs alveolar epithelial barrier
function in vitro. A: Freshly isolated type II cells were either untreated
(Untr) or transduced with lentiviral vectors encoding for control scrambled
shRNA (Con) or were one of two different JAM-Aespeciﬁc shRNAs (sh1,
sh2), were plated on Transwell permeable supports, and were cultured for 6
days to produce model type I cells. The cells were then harvested and lyzed,
and proteins were resolved by SDS-PAGE for immunoblot analysis with an
antibody against JAM-A. JAM-A protein was measured by immunoblot,
quantiﬁed, and normalized to actin. Both JAM-Aespeciﬁc shRNAs signiﬁ-
cantly decreased JAM-A protein expression. B: Representative immuno-
blots. C: Transepithelial resistance (TER) of model type I cells as treated in
A was measured using an EVOM voltmeter. JAM-A depletion resulted in a
signiﬁcant decrease in TER. Data are expressed as means  SD. n Z 3.
*P < 0.05.
Mitchell et alby lung wet/dry weight ratios [wild type: 3.6  0.1 (nZ 3)
versus JAM-A/: 3.6  0.2 (nZ 5)].
Because the lung is composed of many types of cells, we
sought to characterize the effect of depleting JAM-A spe-
ciﬁcally in alveolar epithelial cells. We chose to analyze rat
alveolar epithelial cells because this is a well-established
system that we have used to characterize several different
aspects of alveolar barrier function at a molecular
level.25,31,32 Freshly isolated rat type II cells were trans-
duced with lentiviral constructs encoding for shRNAs
targeting JAM-A or scrambled controls and then further
cultured 6 days to differentiate into model type I cells.
Transduction with two different speciﬁc shRNAs decreased
mean SD JAM-A expression to 44% 10% and 12% 3%
of normal levels (nZ 3), whereas JAM-A expression by cells
transduced with control shRNA was indistinguishable from
that by untreated cells (Figure 2, A and B). Using trans-
epithelial resistance as a measure of barrier function, we found
that JAM-A depletion in primary rat alveolar epithelial cells
reduced transepithelial resistance by approximately 30%
compared with control infected cells (Figure 2C). These
ﬁndings demonstrate that JAM-A expression regulates barrier
function of alveolar epithelial cells.
We then examined the effects of decreased JAM-A
expression on alveolar epithelial tight junction proteins
(Figure 3). Consistent with measurements of total lung ZO-
1 protein levels in JAM-A/ mice, shRNA-mediated
depletion of JAM-A had a signiﬁcant effect on total alve-
olar epithelial ZO-1 levels. Mean  SD ZO-1 protein levels
were reduced to 44%  13% and 36%  11% (n Z 3) of
control values by JAM-A sh1 and sh2, respectively. Simi-
larly, decreases in ZO-1 levels paralleled decreases in
alveolar epithelial transepithelial resistance induced by
these JAM-Aetargeting shRNAs. Total cellular levels of
ZO-2 were not affected by reduced JAM-A expression in
alveolar epithelial cells. This was an unexpected ﬁnding
given the recent report that ZO-2 has a direct association
with JAM-A in intestinal epithelium.15
We next examined the effect of decreased JAM-A expres-
sion on other alveolar epithelial tight junction proteins. JAM-A
protein depletion had no measurable effect on alveolar epithe-
lial expression of claudin-4, claudin-5, claudin-7, or claudin-18.
In contrast to total mouse lung, claudin-10 was not detected in
either control or JAM-Aedepleted rat alveolar epithelial cells,
as determined by immunoblot analysis using an antibody that
recognizes both isoforms (claudin-10a/b). Claudin-15 expres-
sion by rat alveolar epithelial cells was decreased when JAM-A
was depleted, which contrasts with intestinal epithelial cells,
where loss of JAM-A has been reported to result in increased
claudin-15 expression.20 This also differed from the effects of
JAM-A deﬁciency on total lung claudin-15 levels, which was
unchanged in JAM-A/ mice, and may be due to a cell-,
tissue-, or species-speciﬁc difference in claudin-15 regulation.
Critically, in neither case did claudin-15 expression increase
compared with claudin-15 expression in JAM-Aedeﬁcient
intestinal epithelium.20 In addition to the examination of376claudin protein expression, we also assessed the level of
occludin protein and determined that there was no change in
JAM-Aedepleted alveolar epithelial cells (Figure 3).
Claduin-18 has a critical role in regulating lung barrier
function.23,24 Thus, we examined claudin-18 localization
in alveolar epithelial cells. Immunoﬂuorescence analysis
conﬁrmed that depletion of JAM-A disrupted localization of
claudin-18 to tight junctions at sites of cell-cell contact
(Figure 4). Speciﬁcally, cells transduced with JAM-A shRNA
and immunolabeled for claudin-18 showed apparent tight
junction strand breaks and other morphologic abnormalities
(Figure 4). Quantitative analysis of cells transducedwith either
control or JAM-A shRNA revealed that there was a signiﬁcantajp.amjpathol.org - The American Journal of Pathology
Figure 3 JAM-A depletion of alveolar epithelial cells decreases zonula occludens 1 (ZO-1) expression. A: Model type I cells on Transwell permeable supports
that were either untreated (Untr) or transduced with lentiviral vectors encoding for control scrambled shRNA (Con) or were one of two different JAM-Aespeciﬁc
shRNAs (sh1, sh2) were harvested and processed, and the effect on claudin-4 (Cldn-4), Cldn-5, Cldn-7, Cldn-10 Cldn-15, Cldn-18, ZO-1, ZO-2, and occludin levels
was measured by immunoblot analysis and was quantiﬁed. The major tight junction protein affected by JAM-A was ZO-1, which was decreased. Cldn-15 also
showed a signiﬁcant decrease in JAM-Aedepleted cells. B: Representative immunoblots. Data are expressed as means  SD. n Z 3. *P < 0.05.
JAM-A Promotes Tight Junction Assemblyincrease in epithelial cells with disrupted claudin-18 locali-
zation. In contrast to the overt changes observed with
claudin-18, junctional localization of ZO-1 and ZO-2 was
largely unaffected in JAM-Aedepleted alveolar epithelial
cells in culture (Figure 4), despite the net decrease in total
ZO-1 protein levels (Figure 3). However, we cannot rule out
rearrangements in ZO-1 and/or ZO-2 that are below the
level of resolution obtainable by standard confocal immu-
noﬂuorescence microscopy.
Given the known central role for claudin-18 in the formation
of alveolar tight junctions, these data from cultured cellsThe American Journal of Pathology - ajp.amjpathol.orgsuggest that JAM-A regulates claudin-18 processing and,
thereby, maintains alveolar barrier function. JAM-A has pre-
viously been linked to regulation of the actin cytoskeleton via
control of b1 integrin expression.15,40,41 Given this, and the
demonstration that b1 integrin is necessary for optimal
epithelial barrier function,42 we investigated the effect of
JAM-A deﬁciency on actin and b1 integrin expression in
alveolar epithelial cells. JAM-Aedepleted cells had
decreased levels of ﬁlamentous actin compared with control
cells, whereas the total actin protein levels remained un-
changed (Figure 5). JAM-Aedepleted alveolar epithelial cells377
Figure 4 Claudin-18 (Cldn-18) localization is disrupted by JAM-A
depletion. Model type I cells on Transwell permeable supports that were
either untreated (A, D, and G) or transduced with lentiviral vectors
encoding for control scrambled shRNA (B, E, and H) or JAM-Aespeciﬁc
shRNA-1 (C, F, and I) were ﬁxed, permeabilized, and immunolabeled for
Cldn-18 (AeC), zonula occludens 1 (ZO-1) (DeF), or ZO-2 (GeI) and
imaged. Arrowheads in C denote areas where tight junction localization of
Cldn-18 was impaired or absent owing to JAM-A depletion. J: Images from
cells treated with either control scrambled shRNA or one of the two
different JAM-Aetargeted shRNAs were quantiﬁed to determine the number
of cells with disrupted Cldn-18 localization. JAM-A depletion signiﬁcantly
increased the number of cells with impaired Cldn-18. Data are expressed as
means  SD. n Z 5 to 7 ﬁelds from two independent experiments.
*P < 0.05 versus control. Scale bars: 10 mm.
Figure 5 JAM-A depletion disrupts actin and b1 integrin expression.
AeC: Model type I cells on Transwell permeable supports that were trans-
duced with lentiviral vectors encoding for control scrambled shRNA or one of
two different JAM-Aespeciﬁc shRNAs (sh1, sh2) were ﬁxed, permeabilized,
and stained using rhodamine phalloidin. B and C: JAM-A depletion dis-
rupted the formation of ﬁlamentous actin. D: JAM-Aedepleted cells also
showed a signiﬁcant decrease in b1 integrin levels as measured by immu-
noblot and quantiﬁed. E: b1 integrin expression was signiﬁcantly decreased
in JAM-A/ lungs. F: Representative immunoblots. Data are expressed as
means SD. nZ 3 (D); nZ 4 (E). *P< 0.05 versus control. Scale barZ 10
mm. Con, control; Untr, untreated.
Mitchell et alalso showed decreased b1 integrin expression, and cells
transduced with JAM-A sh1 or JAM-A sh2 had b1 integrin
protein levels that were a mean  SD of 66%  6% and
59%  10% of control cells, respectively. A comparable
decrease in b1 integrin protein expression was observed in
JAM-A/ lungs, which had a mean  SD of 63%  5%
(n Z 4) of the b1 integrin content found in wild-type lungs,
consistent with a link between JAM-A and b1 integrin
protein expression.
Given that alveolar barrier function was impaired in
JAM-Aedepleted alveolar epithelial cells, we examined378whether JAM-A/miceweremore susceptible to pulmonary
injury in response to a mild form of endotoxemia induced by
i.p. injection of LPS.43 Histologic hematoxylin and eosin
analyses of lung sections showed that JAM-A/ mice chal-
lenged with i.p. LPS had more cell inﬁltrate into lung air
spaces compared with wild-type controls (Figure 6, AeH).
We further conﬁrmed this observation by immunoblot anal-
ysis of total lung tissue using a broad spectrum marker for
leukocytes (CD11b) that recognizes monocytes, neutrophils,
andmacrophages.44Wild-type and JAM-A/mice showed a
transient, signiﬁcant increase in CD11b-staining cells that
peaked 6 hours after i.p. administration of LPS (Figure 6I). By
this measure, JAM-A/ mice (nZ 6) 6 hours after i.p. LPS
injection had a signiﬁcant relative increase in cellular in-
ﬁltrates that were a mean  SD of 2.1  0.5 fold higher than
that of wild-type mice, consistent with hematoxylin and eosin
images. These results suggest that JAM-A/ mice had
increased sensitivity to mild systemic endotoxemia
compared with wild-type animals, although it is likely that
enhanced motility of JAM-Aedeﬁcient CD11b-positive
cells may also contribute to this response.45 We also exam-
ined lungs 6 hours after injury using an antibody (NIMP-
R14) that recognizes the neutrophil marker Ly6G. Six hoursajp.amjpathol.org - The American Journal of Pathology
Figure 6 JAM-A/ mice have increased
leukocyte recruitment in response to mild systemic
endotoxemia. AeH: Wild-type (AeD) or JAM-A/
(EeH) lungs from uninjured controls (A and E) or
mice 6 hours (B and F), 24 hours (C and G), or 48
hours (D and H) after i.p. injection with 1 mg/kg
endotoxin [lipopolysaccharide (LPS)] were har-
vested, parafﬁn embedded, processed, stained
with hematoxylin and eosin, and imaged as
described in Materials and Methods. JAM-A/
mice showed more cell inﬁltrate than comparably
treated wild-type mice, particularly 24 hours after
treatment (G versus C). I: Lungs from littermate
control mice (wild-type) or JAM-A/ mice were
harvested either immediately (0 hours) or 6, 24, or
48 hours after i.p. injection with 1 mg/kg endo-
toxin (LPS). The lungs were homogenized in a
protease inhibitor cocktail, and then protein
expression was analyzed by immunoblot and
quantiﬁed. Wild-type and JAM-A/ mice had a
signiﬁcant increase in CD11b after injury in
response to i.p. LPS compared with uninjured
mice. The relative increase in CD11b for JAM-A/
mice after injury was signiﬁcantly greater than the
relative increase in CD11b for wild-type mice. J
and K: Lungs from wild-type (J) and JAM-A/ (K)
mice 6 hours after i.p. LPS were harvested, pro-
cessed for immunohistochemical analysis, and
immunolabeled for the neutrophil marker NIMP-
R14. Both wild-type and JAM-A/ mice had
NIMP-R14epositive neutrophils associated with
alveolar septa (arrowheads). Neutrophils were
more apparent in air spaces of injured JAM-A/
mice (arrow). Data are expressed as means  SD.
n Z 4 to 6 (I). *P < 0.05 versus uninjured mice;
yP < 0.05 versus comparably treated wild-type
mice. Scale bars: 100 mm.
JAM-A Promotes Tight Junction Assemblyafter injury, there were Ly6G-positive cells in the air spaces
and in interstitial tissues of wild-type and JAM-A/ lungs,
qualitatively demonstrating that both mouse strains showed
neutrophil recruitment to lungs in response to systemic
endotoxemia (Figure 6, J and K).
Pulmonary edema is also linked to lung injury. Wild-type
littermate controls had a slight, brief increase in pulmonary
edema 6 hours after injection (P Z 0.07, n Z 6) based onThe American Journal of Pathology - ajp.amjpathol.orgwet/dry lung weight (Figure 7). In contrast, JAM-A/ mice
had enhanced edema that was apparent in signiﬁcantly
increased wet/dry lung weights at 6 and 24 hours. Consis-
tent with mild lung injury, pulmonary edema in wild-type
and JAM-A/ mice was transient and resolved 48 hours
after i.p. administration of LPS.
The increased pulmonary edema induced by lung injury
between wild-type and JAM-A/ mice is consistent with379
Figure 7 JAM-A/ mice have increased lung edema to mild systemic
endotoxemia. Lungs from littermate control mice (wild-type, A) or JAM-A/
mice (B) were harvested immediately (Con), 6 hours after i.p.-injected
saline (Sal), or 6, 24, or 48 hours after i.p. injection with 1 mg/kg
endotoxin [lipopolysaccharide (LPS)]. The lungs were weighed, dried
overnight in an oven at 65C, and weighed again, and the ratio of
lung wet/dry weight was calculated. JAM-A/ mice (B) showed a
signiﬁcant increase in wet/dry weight, indicating pulmonary edema.
Data are expressed as means  SD. n Z 7. *P < 0.05 versus unin-
jured mice.
Mitchell et aldysregulation of tight junctions in JAM-A/ mice. Thus,
we examined the effect of systemic endotoxemia on lung
tight junction protein expression in JAM-A/ mice,
initially focusing on the major claudins expressed by alve-
olar epithelial cells: claudin-3, claudin-4, and claudin-18
(Figure 8, AeC and F). Lung claudin-3 expression, which
is largely restricted to type II alveolar epithelial cells, was
unaffected in lungs of either wild-type or JAM-A/ mice in
response to injury (Figure 8A). However, levels of claudin-4
protein in lungs showed a signiﬁcant change in response to
i.p.-administered LPS for wild-type and JAM-A/ mice
(Figure 8B). Lungs from wild-type mice showed a transient
increase in claudin-4 protein expression 6 hours after i.p.
LPS, with levels returning to baseline 24 hours after LPS
challenge. Lungs from JAM-A/ mice also showed a
transient increase in claudin-4 protein expression; however,
the peak occurred 24 hours after i.p. LPS, as opposed to 6
hours for wild-type mice (Figure 8B). In wild-type and
JAM-A/ mice, claudin-4 expression returned to baseline
48 hours after injury. Given the critical role of claudin-4 in
promoting lung ﬂuid clearance,25,28,46 this observed delay in
up-regulation of claudin-4 by JAM-A/ mice has clinical
signiﬁcance. Claudin-18 protein levels were also affected by
i.p. LPS. Lungs from wild-type and JAM-A/ mice
exhibited a comparable, persistent (approximately 30% to
40%) decrease in claudin-18 protein expression (Figure 8C).
Levels of the tight junctioneassociated PDZ binding
scaffold proteins ZO-1 and ZO-2 were also assessed during
the course of lung injury and resolution. Six hours after the
administration of LPS there was a dramatic decrease in
total lung ZO-1 protein levels for wild-type and JAM-A/
mice (Figure 8, D and F). This decrease was transient, and
both strains of mice showed normal levels of lung ZO-1 24
hours after LPS challenge. Whereas lungs from wild-type
mice showed little change in ZO-2 protein levels, lungs
from JAM-A/ mice showed a transient decrease in ZO-2
levels in response to injury (Figure 8, E and F). The
changes observed in lung ZO-2 protein levels mirrored
those of ZO-1 levels, with decreases in ZO-2 protein levels
6 hours after injury and complete recovery of protein levels
24 hours after the administration of LPS. Thus, wild-type
and JAM-A/ mice showed differential regulation of
ZO-2 in response to injury. In particular, the combined
effects of simultaneous decreases in ZO-1 and ZO-2 levels
in JAM-A/ mice correlated with increased edema,
consistent with roles for these scaffold proteins in regu-
lating epithelial barrier function.47,48
Given the differential changes in lung tight junction
protein content between wild-type and JAM-A/ mice
and the effects of JAM-A depletion on claudin-18 locali-
zation, we examined the localization of these tight junction
proteins in lung sections (Figures 9 and 10). Wild-type
mice showed a predominantly linear staining pattern of
localization for claudin-18, ZO-1, and ZO-2 (Figure 9, A,
C, and EeG). However, there were also areas where
junctional localization of these proteins was disrupted.380Uninjured JAM-A/ mice showed a pattern of claudin-18,
ZO-1, and ZO-2 localization comparable with that of wild-
type mice (Figure 9, B, D, and MeO). However, 6 hours
after LPS challenge, JAM-A/ mice showed a signiﬁcant
level of tight junction disruption, where claudin-18, ZO-1,
and ZO-2 seemed to form aggregates as opposed to linear
arrays (Figure 9, QeS). This was in contrast to wild-type
lungs, where localization of these tight junction proteins
was largely unaffected (Figure 9, IeK). Changes to tight
junction proteins in injured JAM-A/ mice were speciﬁc
because localization of the adherens junction protein E-
cadherin was unaffected by injury in either wild-type or
JAM-A/ mice (Figure 9, L and T).
We then further examined changes to claudin-4 and
claudin-18 localization during the time course of injury in
JAM-A/ mice. Claudin-4 showed a patchy distribution
in lung sections consistent with previous results examining
claudin-4 localization in normal rat lung (Figure 10,
AeD).33 The distribution of claudin-4 did not change
much, although qualitatively there did seem to be moreajp.amjpathol.org - The American Journal of Pathology
Figure 8 JAM-A/ mice have an impaired tight junction remodeling response to mild systemic endotoxemia. Lungs from littermate control mice (wild-
type) or JAM-A/ mice were harvested immediately (0 hours), 6 hours after i.p.-injected saline (Sal), or 6, 24, or 48 hours after i.p. injection with 1 mg/kg
endotoxin [lipopolysaccharide (LPS)]. The lungs were homogenized in a protease inhibitor cocktail, and then protein expression was analyzed by immunoblot
for claudin-3 (Cldn-3) (A), Cldn-4 (B), Cldn-18 (C), zonula occludens 1 (ZO-1) (D), and ZO-2 (E) and quantiﬁed. Time 0 quantitation was reproduced from
Figure 1. Both wild-type and JAM-A/ showed a transient increase in Cldn-4 expression; however, this response was delayed in JAM-A/ mice. Cldn-18
expression is uniformly decreased during the entire course of recovery. Both wild-type and JAM-A/ showed a transient decrease in ZO-1 levels. In
contrast, only JAM-A/ mice showed a signiﬁcant decrease in ZO-2 expression 6 hours after i.p. LPS injection. F: Representative immunoblots. Data are
expressed as means  SD. n Z 4 to 6. *P < 0.05 versus uninjured mice.
JAM-A Promotes Tight Junction Assemblyclaudin-4epositive regions of JAM-A/ lungs 24 hours
after LPS challenge compared with the other time points
examined (Figure 10C). Twenty-four hours after the onset
of endotoxemia, claudin-18 localization was comparable
with the 6-hour time point and remained disrupted in JAM-
A/ mice (Figure 10, F and G). Critically, claudin-18
morphologic features renormalized by 48 hours
(Figure 10, E and H), which correlated with the return to
normal lung barrier function after injury (Figure 7).
Taken together, these results support a role for JAM-A in
regulating tight junction protein expression, processing, and
function. In particular, these data suggest that JAM-A plays
a key role in preventing acute lung injury by enabling
alveolar tight junctions to resist aberrant remodeling in
response to systemic endotoxemia.The American Journal of Pathology - ajp.amjpathol.orgDiscussion
Tight junctions are the structural components that regulate
paracellular permeability. To form a suitable and effective
tight junction barrier, the functional coordination of several
classes of transmembrane, scaffold, and cytoskeletal proteins
is required. Herein, we showed that JAM-A expression plays a
key role in the regulation of tight junction dynamics in alveolar
epithelial cells in situ and in cell culture. Speciﬁcally, depletion
of JAM-A led to diminished claudin-18 localization to tight
junctions, decreased ZO-1 and b1 integrin expression, and
compromised actin cytoskeleton assembly. JAM-A deﬁciency
also resulted in misregulation of claudin-4 and ZO-2 in
response to lung injury. Thus, JAM-A plays a key role in
promoting alveolar epithelial tight junction homeostasis and381
Figure 9 Claudin-18 (Cldn-18), zonula occludens 1 (ZO-1), and ZO-2 localization are disrupted in injured JAM-A/ mice. Sections from wild-type (A and
C) and JAM-A/ (B and D) lungs were processed and immunolabeled for Cldn-18. C and D: Magniﬁed insets. Cldn-18 shows normal junctional localization
(arrow) and a pattern indicating disrupted localization (arrowhead). EeT: Lung sections from wild-type (EeL) or JAM-A/ (MeT) mice that were either
uninjured (Con) (EeH and MeP) or 6 hours after lipopolysaccharide (LPS) challenge (IeL and QeT) were processed and immunolabeled for Cldn-18 (E, I, M,
and Q), ZO-1 (F, J, N, and R), ZO-2 (G, K, O, and S), or E-cadherin (E-cad) (H, L, P, and T). Lungs from injured JAM-A/ mice showed more disrupted Cldn-18
(Q), ZO-1 (R), and ZO-2 (S) (arrowheads) than lung sections from wild-type or uninjured JAM-A/ mice which instead had more regions with normal junction
morphology (arrows). UeX: Images were quantiﬁed to determine the percentage of disrupted junctions for Cldn-18 (U), E-cad (V), ZO-1 (W), and ZO-2 (X). For
injured JAM-A/ mice, Cldn-18, ZO-1, and ZO-2 were signiﬁcantly more disrupted than in uninjured wild-type mice. Cldn-18 and ZO-2 in injured JAM-A/
mice were signiﬁcantly more disrupted than in uninjured JAM-A/ mice. Data are expressed as means  SD. *P < 0.05 versus uninjured wild-type mice.
yP < 0.05 versus uninjured JAM-A/ mice. Scale bars: 100 mm (A and C); 20 mm (T).
Mitchell et allung barrier function by coordinating interactions between
claudins, the tight junction scaffold, and the cytoskeleton.
JAM-A/ mice did not exhibit spontaneous lung injury
in the absence of an added insult, suggesting compensatory
changes to adaptive immunity, such as the increase in CD4þ T
cells observed in the intestines of JAM-A/mice.49 However,
JAM-A/ mice showed signiﬁcantly more lung edema when
challenged with systemic endotoxemia as opposed to wild-type
control mice. Increased sensitivity of JAM-A/mice to injury
was due to differences in the regulation of several tight junction
proteins after injury that caused signiﬁcant rearrangement of
several tight junction proteins, including claudin-18, ZO-1, and
ZO-2 (Figure 9, UeX). The enhanced level of tight junction
disruption in JAM-A/ mice compared with wild-type mice
in response to LPS challenge provides a direct mechanism for382the increased sensitivity of JAM-A/ mice to endotoxemia,
particularly when considering the effects of JAM-A depletion
on claudin-18 localization and barrier function in isolated
alveolar epithelial cells (Figures 2C and 4C).
There also was a delay in the up-regulation of lung claudin-4
in JAM-A/mice after injury. Claudin-4 has been shown to
play a key role in preventing pulmonary edema by promoting
lung ﬂuid clearance.25,28,46 Thus, the delay in claudin-4
exhibited by JAM-A/ mice was likely to contribute to
enhanced lung edema observed in JAM-A knockout mice.
Previously published studies show that increased claudin-4
expression promotes lung barrier function and ﬂuid clear-
ance.25,26,28 Consistent with a protective effect of claudin-4,
this protein was increased at 6 hours, which prevented pul-
monary edema in wild-type mice. Critically, this increase inajp.amjpathol.org - The American Journal of Pathology
Figure 10 Recovery of lung claudin (Cldn) localization by JAM-A/ mice 48 hours after lipopolysaccharide (LPS) challenge. Sections from JAM-A/ lungs were
processed and immunolabeled for Cldn-4 (AeD) or Cldn-18 (EeH) 0 (A and E), 6 (B and F), 24 (C and G), or 48 hours (D and H) after LPS challenge. Cldn-4 shows a
limited localization pattern (arrows), as opposed to Cldn-18, which is more prominently expressed. Cldn-18 6 and 24 hours after LPS challenge (F and G) is more
frequently disrupted (arrowheads) than in uninjured JAM-A/ mice (E) or in mice 48 hours after injury (H). I: Images were quantiﬁed to determine the percent
disrupted junctions for claudin-18 during the injury time course. Time 0 and 6 hours quantitation is reproduced from Figure 9. At 48 hours, mice show signiﬁcantly
less Cldn-18 disruption than lungs either 6 or 24 hours after LPS challenge, suggesting full recovery from systemic endotoxemia. Data are expressed as means  SD.
*P < 0.05 versus 6 hours; yP < 0.05 versus 24 hours. Scale bar Z 50 mm.
JAM-A Promotes Tight Junction Assemblyclaudin-4 expression was in the context of well-formed
alveolar tight junctions. In contrast, JAM-A/ not only
had a delay in increased claudin-4 levels but also a signiﬁcant
disruption in tight junction assembly. Thus, any beneﬁcial
effect of increased claudin-4 expression by JAM-A/ mice
was blunted until claudin-18 was able to return to a
normalized state of assembly (Figure 10H). This is critical in
thinking about clinical strategies to improve lung barrier
function in response to systemic endotoxemia because it
implies that up-regulation of claudin-4 alone is not neces-
sarily sufﬁcient to rescue proper lung ﬂuid balance in the
absence of well-formed tight junctions. Consistent with this
model, claudin-18edeﬁcient mice up-regulate lung claudin-4
protein yet still have alveolar barrier dysfunction.24
Two prevailing, complementary models can account for the
ability of JAM-A to enhance barrier function: by recruiting
scaffold proteins to promote tight junction assembly14,15 and
by inducing signaling pathways that alter tight junction protein
composition. It was recently demonstrated that the cytoplasmic
domain of JAM-A binds directly to ZO-2, which, in turn,
helps recruit ZO-1, afadin, PDZ-GTP exchange factor 1 (PDZ-
GEF1), and rap2c into a multiprotein complex that inhibits
cytoskeletal turnover, thereby stabilizing tight junctions.15
JAM-A has been shown to bind directly to ZO-2 with far
greater afﬁnity than to ZO-1,15 although a direct interaction of
JAM-A with ZO-1 in some contexts cannot be completely
ruled out.14,50 We found that wild-type and JAM-A/ mice
showed dramatic decreases in total lung ZO-1 levels 6 hours
after the onset of endotoxemia. However, lungs from
JAM-A/ mice also showed decreased levels of ZO-2.
Because the presence of JAM-A helped stabilize ZO-2
expression in response to injury, the present data areThe American Journal of Pathology - ajp.amjpathol.orgconsistent with a model in which JAM-A recruits ZO-2 to
tight junctions. Given the complementary roles of ZO-1 and
ZO-2 in recruiting claudins to tight junctions,47,48,51 the
present data suggest a mechanism by which ZO-2 com-
pensates for loss of ZO-1 in injured wild-type mice and
implicates a protective role for JAM-A in this process.
A comparable JAM-Aedependent pathway that is regulated
by the formation of a multiprotein scaffold protein complex
has also been shown to modulate intestinal epithelial cell
migration during wound repair. However, instead of co-
clustering PDZ-GEF1 and rap2c to regulate tight junction
permeability, cis-dimerization of JAM-A regulates cell
migration through formation of an afadin/PDZ-GEF2 complex
that activates rap1.41 Activated rap1 inhibits degradation of b1
integrin and promotes cell-matrix interactions, providing a link
between JAM-A and regulation of cell migration.41 Although
JAM-A clustering is a conserved mechanism of action for
diverse cell processes, downstream effects depend on the
nature of the signaling proteins recruited to the complex in
response to JAM-A dimerization. In contrast to intestinal
epithelium, endothelial barrier function is promoted by rap1
activation, indicating that there are tissue-speciﬁc components
of JAM-A signaling that determine how downstream signaling
is processed.52,53
The cytoskeleton is a critical determinant of epithelial
barrier function and serves several regulatory functions.54
Moreover, ﬁlamentous actin has previously been found to
enhance alveolar barrier function, even in the absence of
other changes in tight junction protein expression.55 Thus, by
regulating actin, JAM-A has the capacity to alter tight junc-
tion structure and permeability. Herein, we found that in
JAM-Aedepleted cells there was decreased b1 integrin and a383
Mitchell et alconcomitant decrease in ﬁlamentous actin, demonstrating a
link among JAM-A, actin, and b1 integrin expression. This is
consistent with previous studies linking JAM-A to the
regulation of b1 integrin expression.15,40,41 It is known that
JAM-A induces afadin/rap signaling pathways to increase b1
integrin expression.40,41 JAM-A signaling via a parallel
afadin/rap pathway has also been shown to modulate RhoA
and myosin light chain kinase to strengthen colonic epithelial
barrier function by decreasing tight junction turnover.15 The
present results extend the results of that study by showing
that epithelial b1 integrin is regulated by JAM-A in alveolar
epithelial cells. Similar to b1 integrin, additional integrins
have been found to regulate barrier function. For example,
endothelial tight junctions require signaling by avb3 and
avb5 integrins.56,57 Moreover, studies of MDCK cells
demonstrate that there is a sizable pool of b1 integrin directly
associated with tight junctions, which strengthens barrier
function by promoting interactions between the cytoskeleton
and tight junction proteins,58 and b1 integrin is necessary for
optimal kidney epithelial barrier function.42 Recently, it has
been shown that JAM-A, CD9, and avb5 integrin form a
ternary complex that promotes vascular remodeling and
endothelial cell migration.59 Whether a comparable complex
involving b1 integrin is involved in tight junction assembly
or epithelial barrier function is unknown.
A recent study examining the sensitivity of JAM-A/mice
to direct intratracheal instillation of endotoxin showed that
wild-type and JAM-A/ mice developed comparable levels
of lung edema 6 hours after injury.29 Although these data are in
apparent contrast to the present ﬁnding that JAM-A/ mice
had increased edema in response to systemic endotoxemia, the
method of lung injury used differed from that of the present
study. In particular, intratracheal instillation of endotoxin
directly injures lung epithelium to impair ﬂuid clearance.60 In
contrast, i.p. injection of LPS results in an indirect insult
resulting in lung injury that is signiﬁcantly milder43 and, thus,
revealed increased sensitivity of JAM-A/ mice to pulmo-
nary edema. Moreover, we found that shRNA-mediated
depletion of JAM-A recapitulated the deleterious effect of
JAM-A depletion on tight junctions in vivo, consistent with a
role for JAM-A in regulating lung ﬂuid balance bymaintaining
alveolar barrier function.
Using a model for systemic endotoxemia,43 we found that
JAM-A/ mice have increased pulmonary edema in
response to lung injury. The ability of JAM-A to promote
alveolar epithelial tight junction assembly and remodeling in
response to injury are likely to be the mechanism by which
JAM-A protects the lung from edema that occurs during
sepsis induced by distal organs such as the gut.39,61,62
Herein we provide the ﬁrst direct evidence that JAM-A
has a protective role in preventing lung injury and pro-
moting ﬂuid clearance. The important role of JAM-A in
promoting alveolar barrier function suggests that lung
inﬂammation may also be exacerbated under conditions in
which JAM-A is pathologically impaired. For example, the
airway epithelium of patients with cystic ﬁbrosis contains38450% less JAM-A than do nonecystic ﬁbrosis airway cells
and are more susceptible to barrier dysfunction and para-
cellular leak in response to pro-inﬂammatory cytokines.63
However, the mechanism by which JAM-A expression is
diminished in cystic ﬁbrosis is unknown. Identiﬁcation of
pathways that increase the expression and function of
JAM-A in cystic ﬁbrosis, sepsis, and other conditions is
likely to identify new approaches to promote barrier func-
tion in response to inﬂammation and injury.Acknowledgments
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